Global and United States Type-1 Diabetes Treatment Market Report & Forecast 2022-2028
SKU ID : QYR-20786487 | Publishing Date : 25-Apr-2022
Detailed TOC of Global and United States Type-1 Diabetes Treatment Market Report & Forecast 2022-2028
1 Study Coverage1.1 Type-1 Diabetes Treatment Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Type-1 Diabetes Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Type-1 Diabetes Treatment Market Size for the Year 2017-2028
1.2.2 Global Type-1 Diabetes Treatment Market Size for the Year 2017-2028
1.3 Type-1 Diabetes Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Type-1 Diabetes Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Type-1 Diabetes Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Type-1 Diabetes Treatment Market Dynamics
1.4.1 Type-1 Diabetes Treatment Industry Trends
1.4.2 Type-1 Diabetes Treatment Market Drivers
1.4.3 Type-1 Diabetes Treatment Market Challenges
1.4.4 Type-1 Diabetes Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Type-1 Diabetes Treatment by Type
2.1 Type-1 Diabetes Treatment Market Segment by Type
2.1.1 Rapid-Acting Insulin
2.1.2 Short-Acting Insulin
2.1.3 Others
2.2 Global Type-1 Diabetes Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Type-1 Diabetes Treatment Market Size by Type (2017-2028)
2.4 United States Type-1 Diabetes Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Type-1 Diabetes Treatment Market Size by Type (2017-2028)
3 Type-1 Diabetes Treatment by Application
3.1 Type-1 Diabetes Treatment Market Segment by Application
3.1.1 Hospitals & Clinics
3.1.2 Academic & Research Institutes
3.2 Global Type-1 Diabetes Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Type-1 Diabetes Treatment Market Size by Application (2017-2028)
3.4 United States Type-1 Diabetes Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Type-1 Diabetes Treatment Market Size by Application (2017-2028)
4 Global Type-1 Diabetes Treatment Competitor Landscape by Company
4.1 Global Type-1 Diabetes Treatment Market Size by Company
4.1.1 Top Global Type-1 Diabetes Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Type-1 Diabetes Treatment Revenue by Player (2017-2022)
4.2 Global Type-1 Diabetes Treatment Concentration Ratio (CR)
4.2.1 Type-1 Diabetes Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Type-1 Diabetes Treatment in 2021
4.2.3 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Type-1 Diabetes Treatment Headquarters, Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Type-1 Diabetes Treatment Headquarters and Area Served
4.3.2 Global Type-1 Diabetes Treatment Companies Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Type-1 Diabetes Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Type-1 Diabetes Treatment Market Size by Company
4.5.1 Top Type-1 Diabetes Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Type-1 Diabetes Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Type-1 Diabetes Treatment Market Size by Region
5.1 Global Type-1 Diabetes Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Type-1 Diabetes Treatment Market Size by Region (2017-2028)
5.2.1 Global Type-1 Diabetes Treatment Market Size by Region: 2017-2022
5.2.2 Global Type-1 Diabetes Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Type-1 Diabetes Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Type-1 Diabetes Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Type-1 Diabetes Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Astellas Pharma
7.1.1 Astellas Pharma Company Details
7.1.2 Astellas Pharma Business Overview
7.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
7.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.1.5 Astellas Pharma Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Type-1 Diabetes Treatment Introduction
7.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.2.5 Merck Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Company Details
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
7.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.3.5 Eli Lilly Recent Development
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Details
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
7.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.4.5 Novo Nordisk Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Details
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Type-1 Diabetes Treatment Introduction
7.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.5.5 Sanofi Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Details
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
7.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.6.5 AstraZeneca Recent Development
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Company Details
7.7.2 Boehringer Ingelheim GmbH Business Overview
7.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
7.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.7.5 Boehringer Ingelheim GmbH Recent Development
7.8 Novartis
7.8.1 Novartis Company Details
7.8.2 Novartis Business Overview
7.8.3 Novartis Type-1 Diabetes Treatment Introduction
7.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.8.5 Novartis Recent Development
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Details
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
7.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.9.5 Pfizer Inc. Recent Development
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Company Details
7.10.2 Abbott Laboratories Business Overview
7.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
7.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.10.5 Abbott Laboratories Recent Development
7.11 Mannkind Corporation
7.11.1 Mannkind Corporation Company Details
7.11.2 Mannkind Corporation Business Overview
7.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
7.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.11.5 Mannkind Corporation Recent Development
7.12 Braun Melsungen AG
7.12.1 Braun Melsungen AG Company Details
7.12.2 Braun Melsungen AG Business Overview
7.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
7.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.12.5 Braun Melsungen AG Recent Development
7.13 Macrogenics, Inc.
7.13.1 Macrogenics, Inc. Company Details
7.13.2 Macrogenics, Inc. Business Overview
7.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
7.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022)
7.13.5 Macrogenics, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Type-1 Diabetes Treatment Market Report & Forecast 2022-2028
List of TablesTable 1. Type-1 Diabetes Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Type-1 Diabetes Treatment Market Trends
Table 3. Type-1 Diabetes Treatment Market Drivers
Table 4. Type-1 Diabetes Treatment Market Challenges
Table 5. Type-1 Diabetes Treatment Market Restraints
Table 6. Global Type-1 Diabetes Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Type-1 Diabetes Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Type-1 Diabetes Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Type-1 Diabetes Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Type-1 Diabetes Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Type-1 Diabetes Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Type-1 Diabetes Treatment Revenue Share by Player, 2017-2022
Table 13. Global Type-1 Diabetes Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Type-1 Diabetes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2021)
Table 15. Top Players of Type-1 Diabetes Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Type-1 Diabetes Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Type-1 Diabetes Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Type-1 Diabetes Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Type-1 Diabetes Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Type-1 Diabetes Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Type-1 Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Type-1 Diabetes Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Type-1 Diabetes Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Type-1 Diabetes Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Astellas Pharma Company Details
Table 31. Astellas Pharma Business Overview
Table 32. Astellas Pharma Type-1 Diabetes Treatment Product
Table 33. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 34. Astellas Pharma Recent Development
Table 35. Merck Company Details
Table 36. Merck Business Overview
Table 37. Merck Type-1 Diabetes Treatment Product
Table 38. Merck Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 39. Merck Recent Development
Table 40. Eli Lilly Company Details
Table 41. Eli Lilly Business Overview
Table 42. Eli Lilly Type-1 Diabetes Treatment Product
Table 43. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 44. Eli Lilly Recent Development
Table 45. Novo Nordisk Company Details
Table 46. Novo Nordisk Business Overview
Table 47. Novo Nordisk Type-1 Diabetes Treatment Product
Table 48. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 49. Novo Nordisk Recent Development
Table 50. Sanofi Company Details
Table 51. Sanofi Business Overview
Table 52. Sanofi Type-1 Diabetes Treatment Product
Table 53. Sanofi Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 54. Sanofi Recent Development
Table 55. AstraZeneca Company Details
Table 56. AstraZeneca Business Overview
Table 57. AstraZeneca Type-1 Diabetes Treatment Product
Table 58. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 59. AstraZeneca Recent Development
Table 60. Boehringer Ingelheim GmbH Company Details
Table 61. Boehringer Ingelheim GmbH Business Overview
Table 62. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product
Table 63. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 64. Boehringer Ingelheim GmbH Recent Development
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Novartis Type-1 Diabetes Treatment Product
Table 68. Novartis Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Pfizer Inc. Company Details
Table 71. Pfizer Inc. Business Overview
Table 72. Pfizer Inc. Type-1 Diabetes Treatment Product
Table 73. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 74. Pfizer Inc. Recent Development
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Type-1 Diabetes Treatment Product
Table 78. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 79. Abbott Laboratories Recent Development
Table 80. Mannkind Corporation Company Details
Table 81. Mannkind Corporation Business Overview
Table 82. Mannkind Corporation Type-1 Diabetes Treatment Product
Table 83. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 84. Mannkind Corporation Recent Development
Table 85. Braun Melsungen AG Company Details
Table 86. Braun Melsungen AG Business Overview
Table 87. Braun Melsungen AG Type-1 Diabetes Treatment Product
Table 88. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 89. Braun Melsungen AG Recent Development
Table 90. Macrogenics, Inc. Company Details
Table 91. Macrogenics, Inc. Business Overview
Table 92. Macrogenics, Inc. Type-1 Diabetes Treatment Product
Table 93. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 94. Macrogenics, Inc. Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Type-1 Diabetes Treatment Product Picture
Figure 2. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Type-1 Diabetes Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Type-1 Diabetes Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Type-1 Diabetes Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Type-1 Diabetes Treatment Market Share in Global 2017-2028
Figure 7. Type-1 Diabetes Treatment Report Years Considered
Figure 8. Product Picture of Rapid-Acting Insulin
Figure 9. Product Picture of Short-Acting Insulin
Figure 10. Product Picture of Others
Figure 11. Global Type-1 Diabetes Treatment Market Share by Type in 2022 & 2028
Figure 12. Global Type-1 Diabetes Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Type-1 Diabetes Treatment Market Share by Type (2017-2028)
Figure 14. United States Type-1 Diabetes Treatment Market Share by Type in 2022 & 2028
Figure 15. United States Type-1 Diabetes Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Type-1 Diabetes Treatment Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospitals & Clinics
Figure 18. Product Picture of Academic & Research Institutes
Figure 19. Global Type-1 Diabetes Treatment Market Share by Application in 2022 & 2028
Figure 20. Global Type-1 Diabetes Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Type-1 Diabetes Treatment Market Share by Application (2017-2028)
Figure 22. United States Type-1 Diabetes Treatment Market Share by Application in 2022 & 2028
Figure 23. United States Type-1 Diabetes Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Type-1 Diabetes Treatment Market Share by Application (2017-2028)
Figure 25. North America Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Type-1 Diabetes Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Type-1 Diabetes Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 54. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 55. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 56. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 57. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 58. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 61. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 62. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 63. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 64. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 65. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Keyplayers in Global and United States Type-1 Diabetes Treatment Market Report & Forecast 2022-2028
Astellas PharmaMerck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.